What happened
CG Invites updated a previously disclosed supply contract with Korea Research Institute of Bioscience and Biotechnology, now worth US$4.26M, about 117.59% of its recent annual revenue, running through Dec 2026.
For context, this single contract equals about 117.59% of the company's most recent annual revenue.
| Counterparty | Korea Research Institute of Bioscience and Biotechnology |
|---|---|
| Contract value | US$4.26M |
| vs. recent revenue | 117.59% |
| Through | Dec 2026 (from Dec 2024) |
| Filed | 2026-09-10, [Amended] Supply contract signed |
| Source | DART rcept 20260910900166 → open original filing |
Source: DART. Information only, not investment advice.